Pharma Journalist 9001 posts 0 comments

Novo Nordisk has announced the U.S. launch of Ozempic® (semaglutide) tablets, marking a significant expansion of its blockbuster diabetes franchise by introducing an oral version of the…
Read More...

Arrowhead Pharmaceuticals, Inc. has announced that Australia’s Therapeutic Goods Administration (TGA) has approved REDEMPLO® (plozasiran), marking the first authorized treatment in the…
Read More...

Gilead Sciences has finalized its acquisition of Arcellx, completing a deal valued at approximately $7.8 billion. The transaction marks a strategic expansion of Gilead’s oncology…
Read More...

Novartis has secured approval from the European Commission for its novel therapy Rhapsido, marking a significant advancement in the treatment of chronic spontaneous urticaria (CSU). The…
Read More...

Eli Lilly and Company has announced a definitive agreement to acquire Ajax Therapeutics, a move aimed at strengthening its oncology pipeline with a next-generation treatment for blood…
Read More...

AstraZeneca has received approval from the U.S. Food and Drug Administration for a new self-administered version of its lupus treatment, Saphnelo, marking a significant step forward in…
Read More...

BioMarin Pharmaceutical Inc. has finalized its acquisition of Amicus Therapeutics in an all-cash deal valued at approximately $4.8 billion, marking a significant expansion of its rare…
Read More...

Sun Pharmaceutical Industries Limited has announced a landmark agreement to acquire Organon & Co. in an all-cash transaction valued at approximately $11.75 billion. Under the terms…
Read More...

Leinco Technologies and CellCarta have announced a strategic collaboration to enhance proteomics solutions aimed at supporting immuno-oncology research and the development of targeted…
Read More...

Cipla Limited and its wholly owned subsidiary Cipla USA Inc. have secured final approval from the U.S. Food and Drug Administration (USFDA) for their Abbreviated New Drug Application…
Read More...